MVIS US Listed Biotech 25 Index ETF Overview

With 1 ETF traded in the U.S. markets, MVIS US Listed Biotech 25 Index ETF gathers total assets under management of $487.49M. The average expense ratio is 0.35%. MVIS US Listed Biotech 25 Index ETF can be found in the following asset class:

  • Equity

ETF Basics

Best Biotech ETFs by Performance

See the top-performing biotech ETFs and the potential benefits of investing. Analysis

Finding The Best Biotech ETF

It's easy to be blinded by headline numbers. The rally in biotech isn't so simple.

Daily ETF Watch

Daily ETF Watch: Institutional Use Grows

ETFs are becoming core holdings for institutions.

Features and News

5 High-Flying 2013 Niche ETF Sectors

High-flying ETFs in several sectors eclipsed the S&P 500 gains.

Features and News

Biotech ETF Among 2013 Best Performers

Multiple factors are setting the sector up for further growth in 2014.

Features and News

Best ETFs In 2013: DBJP, Tesla-Fueled QCLN

The latest tally of year-to-date top-10-performing ETFs include Japan, clean energy and biotech funds, to name a few. Analysis

EGPT And Beyond: 2012’s Top ETFs So Far

Who knew Egypt would be the best ETF as the third quarter draws to a close?